Working… Menu
Trial record 1 of 1 for:    apalutamide | titan
Previous Study | Return to List | Next Study

A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC (TITAN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02489318
Recruitment Status : Active, not recruiting
First Posted : July 3, 2015
Last Update Posted : June 27, 2019
Information provided by (Responsible Party):
Aragon Pharmaceuticals, Inc.